diabetes
Showing NaN - NaN of 79
Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin glargine, insulin degludec, metformin)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- insulin glargine
- +2 more
-
Inglewood, California
- +28 more
Jan 19, 2017
Study Focus: 30-day Rehospitalizations Among At-risk Older Adults Randomized to a Social Work-driven Care Transitions
Completed
- Study Focus: 30-day Rehospitalizations Among At-risk Older Adults Randomized to a Social Work-driven Care Transitions Intervention
- +9 more
- SWIFT home intervention
-
Los Angeles, California
- +1 more
Dec 19, 2016
Diabetes, Diabetes, Type 2 Trial in Puerto Rico, United States (repaglinide and metformin combination tablet, rosiglitazone and
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- repaglinide and metformin combination tablet
- rosiglitazone and metformin combination tablet
-
Vestavia, Alabama
- +102 more
Feb 9, 2017
Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec, insulin glargine)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- insulin degludec
- insulin glargine
-
Bay Minette, Alabama
- +186 more
Dec 16, 2016
Diabetes, Diabetes, Type 2 Trial in Canada, Puerto Rico, United States (insulin detemir, insulin glargine, insulin aspart)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- insulin detemir
- +2 more
-
Birmingham, Alabama
- +77 more
Jan 30, 2017
Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin detemir, insulin NPH)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- insulin detemir
- insulin NPH
-
Birmingham, Alabama
- +95 more
Jan 27, 2017
Diabetes, Diabetes, Type 2 Trial in Worldwide (liraglutide, )
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- liraglutide
- placebo
-
Cypress, California
- +19 more
Jan 25, 2017
Diabetes, Diabetes, Type 2 Trial in Canada, United States (liraglutide, rosiglitazone, metformin)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- liraglutide
- +2 more
-
Goodyear, Arizona
- +88 more
Jan 24, 2017
Diabetes, Diabetes, Type 2 Trial in United States (biphasic insulin aspart, pioglitazone, metformin)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- biphasic insulin aspart
- +2 more
-
Birmingham, Alabama
- +72 more
Jan 10, 2017
Diabetes, Diabetes, Type 2 Trial in United States (biphasic insulin aspart, insulin glargine, metformin)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- biphasic insulin aspart
- +3 more
-
Concord, California
- +26 more
Jan 6, 2017
Diabetes, Diabetes, Type 1 Trial in United States (insulin human, insulin lispro, insulin aspart)
Completed
- Diabetes
- Diabetes Mellitus, Type 1
- insulin human
- +2 more
-
Birmingham, Alabama
- +75 more
Dec 21, 2016
Diabetes, Diabetes, Type 2 Trial in Worldwide (insulin degludec/insulin aspart, insulin glargine)
Completed
- Diabetes
- Diabetes Mellitus, Type 2
- insulin degludec/insulin aspart
- insulin glargine
-
Birmingham, Alabama
- +91 more
Oct 26, 2016
Do Patient-Centric mHealth Programs Improve Patient Engagement
Unknown status
- Diabetes
- "IntelliH"
-
Los Angeles, CaliforniaCedars-Sinai Medical Center
May 11, 2016
Diabetes Trial in United States (Investigational Blood Glucose Monitoring System)
Completed
- Diabetes
- Investigational Blood Glucose Monitoring System
-
Escondido, California
- +3 more
Jan 29, 2016
Diabetes Trial in United States (Thymosin Beta 4 (Tß4), Placebo)
Terminated
- Diabetes
- Thymosin Beta 4 (Tβ4)
- Placebo
-
Inglewood, California
- +4 more
Jun 10, 2015
Clinical Utility of SUDOSCAN in the Pediatric Population
Withdrawn
- Childhood Obesity
- +2 more
-
Los Angeles, CaliforniaUniversity of Southern California's Childhood Obesity Research C
Nov 7, 2014
Plantar Ulcer, Diabetes, Neuropathy Causing Loss of Protective Sensation Trial in United States (TrueContour® Insole, Current
Completed
- Plantar Ulcer
- +2 more
- TrueContour® Insole
- Current standard of care insole
-
Phoenix, Arizona
- +10 more
Aug 12, 2014
Gastroparesis, Diabetic Gastroparesis, Diabetes Trial in United States (metoclopramide, Placebo)
Diabetes Trial in Los Angeles (Daily text messages)
Completed
- Diabetes
- Daily text messages
-
Los Angeles, CaliforniaUniversity of Southern California
Jun 18, 2013
Diabetes Trial in United States (Phentermine/Topiramate, Placebo)
Diabetes, Chronic Diseases Trial in Los Angeles (Self-Care Stimulating Disease Prevention Program, Fighting Cancer with Advice)
Completed
- Diabetes
- Chronic Diseases
- Self-Care Stimulating Disease Prevention Program
- Fighting Cancer with Advice
-
Los Angeles, California
- +1 more
Jun 6, 2011